Maria Santoro
The residual antiviral activity of HIV agents: facts or myths?
Materiali
The residual antiviral activity of HIV agents: facts or myths?
Benefits achieved by the intensification strategy in HIV therapy
Monotherapy for HIV infection: game over?
Less Drug Regimens in HIV treatment: the evolution of underperforming to performing
/assets/5-14-Giacomelli.pdf
Real life data of 2-drug therapy: oral and Long Acting - CAB-RPV Long Acting
/assets/7-14-Ripamonti.pdf
Review of Clinical experiences: Dual Therapy and Long Acting
Review of Clinical experiences: Dual Therapy and Long Acting
Review of Clinical experiences: Dual Therapy and Long Acting